Latest Articles

Publication Date
The Role and Mechanism of Incretins in Gynaecologic Diseases.

Obesity is a major global public health concern closely linked to the development and progression of various gynaecological disorders, particularly polycystic ovary syndrome (PCOS) and endometrial cancer. Incretins, a group …

Published: Sept. 26, 2026, midnight
Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report - Cureus

Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report Cureus

Published: Sept. 25, 2026, 8:57 a.m.
Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report - cureus.com

Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report cureus.com

Published: Sept. 25, 2026, 8:57 a.m.
Research progress on the role of IL‑37 in gynecological and obstetrics‑related diseases (Review).

Interleukin 37 (IL‑37), a member of the IL‑1 family, is recognized as an anti‑inflammatory cytokine. The anti‑inflammatory properties of recombinant human (rh)IL‑37 have been confirmed in vitro and its protective …

Published: Sept. 25, 2026, midnight
Mayo Clinic Minute: Fertility-sparing treatment of endometrial cancer (VIDEO) - Mayo Clinic News Network

Mayo Clinic Minute: Fertility-sparing treatment of endometrial cancer (VIDEO) Mayo Clinic News Network

Published: Sept. 24, 2026, 1:33 p.m.
Mayo Clinic Minute: Fertility-sparing treatment of endometrial cancer (VIDEO) - newsnetwork.mayoclinic.org

Mayo Clinic Minute: Fertility-sparing treatment of endometrial cancer (VIDEO) newsnetwork.mayoclinic.org

Published: Sept. 24, 2026, 1:33 p.m.
Accessory cavitated uterine mass presenting as refractory dysmenorrhoea: a diagnostic challenge.

A woman in her 20s presented with severe progressive dysmenorrhoea that began within 1-2 years of menarche, was refractory to medical therapy and required repeated emergency department visits for parenteral …

Published: Sept. 24, 2026, midnight
Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling - Bioengineer.org

Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling Bioengineer.org

Published: Sept. 23, 2026, 1:24 a.m.
Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling - bioengineer.org

Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling bioengineer.org

Published: Sept. 23, 2026, 1:24 a.m.
YTHDF3 promotes angiogenesis in endometriosis by enhancing the translation efficiency of PFKFB3.

Angiogenesis plays a critical role in the progression of endometriosis, with enhanced glycolysis accelerating pathological angiogenesis. Prior research has identified a central role for N6-methyladenosine (m6A) modification in regulating glycolytic …

Published: Sept. 23, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!